Comparison
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 vs 45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Fetoplacental Androgens Excess and 45 X 46 XY Mixed Gonadal Dysgenesis CN279762 for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
A condition where the placenta and fetus together produce excess androgens, affecting an XX embryo's development. It is present at birth. Multidisciplinary care helps manage physical and hormonal aspects.
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
A chromosomal variation affecting sexual development. Involves differences in gonadal tissue and may affect physical development. Care involves hormonal support and multidisciplinary management.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
Variable
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
0-0
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
severe
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
Chronic
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
No
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
reproductive
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
reproductive
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
endocrine
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-fetoplacental-androgens-excess-C5679876 and 45-x-46-xy-mixed-gonadal-dysgenesis-CN279762 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 | 45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762 | Discriminating power |
|---|---|---|---|
| Genital appearance at birth | May show androgen-related atypical genital development in an XX embryo; exact features vary. | May show variable genital or gonadal development related to mosaic gonadal tissue. | Moderate |
| Gonadal development | Gonads are not primarily defined as dysgenetic by the supplied description. | Differences in gonadal tissue are characteristic, but tissue type requires specialist assessment. | High |
| Associated growth or Turner-like features | Not established from the supplied source; do not assume extra features. | Physical development may be affected, but specific features and frequency are not established here. | Low |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 when
Confirmed 46,XX karyotype with evidence pointing to prenatal androgen excess
The supplied mechanism is excess androgen production involving fetus and placenta.
High
No mosaicism is identified after appropriate chromosomal testing
Absence of 45,X/46,XY mosaicism favors considering the XX androgen-excess condition.
Moderate
Endocrine evaluation supports androgen excess rather than primary gonadal dysgenesis
Category differs: endocrine for left versus genetic for right.
Moderate
Choose 45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762 when
Karyotype demonstrates 45,X/46,XY mosaicism
Chromosomal variation is the defining supplied feature.
High
Evaluation shows differing or dysgenetic gonadal tissue
Mixed gonadal development is central to this condition.
Moderate
Clinical concern centers on chromosomal DSD rather than fetoplacental androgen excess
Etiology and category differ despite overlap in genital findings.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 | 45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762 | Interpretation |
|---|---|---|---|
| Karyotype or chromosomal microarray | 46,XX without the stated mosaicism, if confirmed. | 45,X/46,XY mosaicism, if confirmed. | Chromosomal result is the main discriminator; testing method and interpretation belong to specialists. |
| Endocrine androgen assessment | May support excess androgen exposure, but no cutoff is supplied. | Results may vary and do not replace chromosomal diagnosis. | An abnormal hormone result is not itself a diagnosis. |
| Gonadal imaging or histology | No specific gonadal pattern is established here. | May show differing gonadal tissue; histology requires specialist review. | Imaging or histology can support, but not independently prove, the diagnosis. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
- Outcome
- Chronic condition with individualized outcome; exact prognosis is not established.
- Factors
- Androgen effects, assigned care goals, and associated findings may influence course.
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
- Outcome
- Chronic chromosomal condition with variable development and gonadal function.
- Factors
- Mosaic pattern, gonadal tissue, hormone function, and associated physical findings may matter.
Time frame: Lifelong follow-up may be considered; no specific timeline is established.
Clinician interpretation should integrate genetics, hormones, anatomy, and patient or family priorities.
Complications comparison
| Complication | Presentation |
|---|---|
| Hormonal imbalance | Androgen-related effects may need endocrine follow-up. Hormonal support may be needed, depending on gonadal function. Needs and timing are individualized; no doses are established here. |
| Gonadal or fertility concerns | Fertility implications are not established by the supplied data. Dysgenetic gonadal tissue may affect fertility and requires specialist counseling. Avoid assumptions about cancer risk or reproductive outcome without evaluation. |
| Psychosocial impact | Severe designation may reflect complex care needs, not a measured outcome. Moderate designation does not exclude significant personal impact. Support should be tailored; comparative burden is not quantified. |
Patient education highlights
- HighDiagnosis
Ask how karyotype, hormone tests, and gonadal findings were interpreted; one abnormal result is not a complete diagnosis.
- HighCare team
Both conditions generally need multidisciplinary endocrine, genetics, and psychosocial care.
- MediumUncertainty
Specific symptoms, risks, fertility, and long-term outcomes vary and are not fully established here.